AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Each Tablet Contains: Etoricoxib 120,0 Mg

9 registrations across 1 African market— 9 active

Markets with Each Tablet Contains: Etoricoxib 120,0 Mg

🇿🇦South Africa
9 registrations
9 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
BRUTASULT 120🇿🇦South AfricaEvohealth (Pty) LtdactiveJun 2031
EXTRIB 120 mg🇿🇦South AfricaPharma Dynamics (Pty) LtdactiveMay 2031
ETORICOXIB 120 BIOTECH🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveMar 2031
AZCURA 120🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 2031
ETORICOXIB ZYDUS 120🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 2031
ETIFLAM 120🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 2031
THRYTIX 120🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveDec 2030
EBOV 120🇿🇦South AfricaActivo Health (Pty) LtdactiveNov 2030
ECOXAR 120🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveNov 2025

Each Tablet Contains: Etoricoxib 120,0 Mg in Africa — Regulatory Overview

Each Tablet Contains: Etoricoxib 120,0 Mg is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.